Header lorem ipsum dolor
As the industry’s first complete real world evidence (RWE) solution, Target RWE cultivates a distinctly collaborative enterprise that unifies unique real world data (RWD) and advanced RWE analytics in a cohesive ecosystem to improve lives
Tabs
Nam dignissim ante gravida tortor vulputate blandit. Suspendisse ac dolor ut orci varius dignissim sit amet vel nulla. Aliquam ac vestibulum enim, non sodales turpis. Proin dapibus metus ac lectus viverra, at fermentum lorem pulvinar. Morbi tempus tempor condimentum. Ut hendrerit consequat arcu.
Test Button
Nam dignissim ante gravida tortor vulputate blandit. Suspendisse ac dolor ut orci varius dignissim sit amet vel nulla. Aliquam ac vestibulum enim, non sodales turpis. Proin dapibus metus ac lectus viverra, at fermentum lorem pulvinar. Morbi tempus tempor condimentum. Ut hendrerit consequat arcu.
Learn More
Nam dignissim ante gravida tortor vulputate blandit. Suspendisse ac dolor ut orci varius dignissim sit amet vel nulla. Aliquam ac vestibulum enim, non sodales turpis. Proin dapibus metus ac lectus viverra, at fermentum lorem pulvinar. Morbi tempus tempor condimentum. Ut hendrerit consequat arcu.
Learn More
Nam dignissim ante gravida tortor vulputate blandit. Suspendisse ac dolor ut orci varius dignissim sit amet vel nulla. Aliquam ac vestibulum enim, non sodales turpis. Proin dapibus metus ac lectus viverra, at fermentum lorem pulvinar. Morbi tempus tempor condimentum. Ut hendrerit consequat arcu.
Learn More
Tabs-White
Inform Drug Pipeline Progression
Target RWE provides an easier, more feasible avenue to generate and analyze real world patient data. Target RWE’s turnkey Community solution allows partners to rapidly and seamlessly engage in existing and newly activated disease communities through longitudinal, observational real world data registries. Follow patients through more than 8 years of longitudinal patient journeys with the breadth and depth that only our multi-modal data collection and processing platform can deliver.
Learn More
Inform Drug Pipeline Progression
Target RWE provides an easier, more feasible avenue to generate and analyze real world patient data. Target RWE’s turnkey Community solution allows partners to rapidly and seamlessly engage in existing and newly activated disease communities through longitudinal, observational real world data registries. Follow patients through more than 8 years of longitudinal patient journeys with the breadth and depth that only our multi-modal data collection and processing platform can deliver.

Inform Drug Pipeline Progression
Target RWE provides an easier, more feasible avenue to generate and analyze real world patient data. Target RWE’s turnkey Community solution allows partners to rapidly and seamlessly engage in existing and newly activated disease communities through longitudinal, observational real world data registries. Follow patients through more than 8 years of longitudinal patient journeys with the breadth and depth that only our multi-modal data collection and processing platform can deliver.
Contact Us
Carousel With Image and Text
Carousel With Image and Text (NO BACKGROUND IMAGE)
CTA Square - Blue
Sed ut perspiciatis unde omnis iste
CTA Square - Orange
Sed ut perspiciatis unde omnis iste
Content Button
Color Box
Genome sequencing
Longitudinally analyze patients complete genetic profile to understand and categorize how specific diseases form and affect patients with similar genetic risk factors. At scale, this can be used to/for xxxxx
Genotyping
Analyze and group patients with identical genetic structure and treatment regimens to enable casual relation of therapeutic response to consistent treatments across patient cohorts with identical genotypes.
Biomarker Characterizations
Identify similar biomarkers for patients cohorts in early stages of a disease's natural progression to evaluate their risk of disease on set and their therapeutic response once initial treatment has started.
Diagnostics Assay Development & Validation
Evaluate drug activity within genetically and clinically screened patient cohorts to associate drug effectiveness outcomes with genetic risk factors at various stages of patient’s treatment journey. At scale, this can be used to/for xxxx
Color Box
This is a section with a grey background.
Accordion
teste
test
Communities Accordion

Perform longitudinal studies to evaluate and stratify patients' disease activity along their treatment journey to correlate patient outcomes to consistent treatment regimens.
Learn Moretest
Post Marketing Requirements and PASS Studies
New Drug Application and label enhancement
Product experience, utilization, and exploratory strategies